Kalaris Therapeutics KLRS
NASDAQ KLRS
$2.90 +0.06 (+1.93%)
At close: Sep 29, 2026 · 4:00 PM EDT

Kalaris Therapeutics (KLRS) Total Current Liabilities (2019 - 2026)

Updated

Kalaris Therapeutics (KLRS) recorded Total Current Liabilities of $8.74 million in Q2 2026, up 14.2% from $7.65 million a year earlier and up 8.2% from the prior quarter.

Analysis

Kalaris Therapeutics (KLRS) Total Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, Kalaris Therapeutics reported Total Current Liabilities of $9.71 million, down 60.7% from FY2024.

  • Annual Total Current Liabilities has a five-year compound annual growth rate of -4.6% (FY2020 to FY2025).
  • Across earlier years, Total Current Liabilities came in at $24.7 million in FY2024 (-12.9%), $28.37 million in FY2023 (+16.6%), $24.34 million in FY2022 (-35.7%) and $37.85 million in FY2021 (+207.9%).
  • Quarterly Total Current Liabilities has ranged from $1.41 million in Q3 2024 to $37.85 million in Q4 2021 over the past five years.
  • On a year-over-year basis, Total Current Liabilities rose in four of the last eight quarters, with growth averaging 50.6%.
  • Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 329.5% in Q3 2025, against a decline of 95.7% in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $8.08 million (Q1 2026), $9.71 million (Q4 2025) and $6.07 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Kalaris Therapeutics 67.84 Mn 67.84 Mn - 8.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.74 Mn
Mar 31, 2026 8.08 Mn
Dec 31, 2025 9.71 Mn
Sep 30, 2025 6.07 Mn
Jun 30, 2025 7.65 Mn
Mar 31, 2025 7.14 Mn
Dec 31, 2024 24.70 Mn
Sep 30, 2024 1.41 Mn
Jun 30, 2024 2.36 Mn
Mar 31, 2024 7.66 Mn
Dec 31, 2023 28.37 Mn
Sep 30, 2023 33.07 Mn
Jun 30, 2023 30.56 Mn
Mar 31, 2023 24.96 Mn
Dec 31, 2022 24.34 Mn
Sep 30, 2022 20.72 Mn
Jun 30, 2022 21.59 Mn
Mar 31, 2022 18.64 Mn
Dec 31, 2021 37.85 Mn
Sep 30, 2021 24.17 Mn
API Access

Kalaris Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=KLRS&period=max&api_key=YOUR_API_KEY